Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I'm no math wiz

<< Previous

Bullboard Posts

Next >>

Post by Rumpl3StiltSkinon Apr 05, 2022 9:12am

237 Views

Post# 34576064

I'm no math wiz

But from what i am seeing this is still an early snapshot with plenty of potential still here. Didn't
one of the TLT Boards Doctors say 30% CR would be 'Great' ?? So it seems to me if final CR %s are in the 40s 50s or 60s TLT will be THE standard of care for NMIBC, and perhaps other cancers off lable...

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?